Key Points
- Heartflow CEO John C.M. Farquhar sold 22,562 shares on June 10 at an average price of $28.50, generating about $643,017. The sale was made under a pre-arranged Rule 10b5-1 plan, and his remaining stake was valued at roughly $14.16 million.
- The CEO has been actively reducing his position, with similar sales in May, April, and March at prices ranging from $25.00 to $29.12. The June transaction represented a 4.34% decrease in his holdings.
- Heartflow recently reported better-than-expected quarterly results, posting a smaller-than-expected loss of $0.16 per share as revenue rose 41.3% year over year to $52.59 million. Wall Street remains broadly positive, with a consensus rating of Moderate Buy and an average price target of $37.00.
Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CEO John C.M. Farquhar sold 22,562 shares of the company's stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $28.50, for a total transaction of $643,017.00. Following the transaction, the chief executive officer owned 496,835 shares in the company, valued at approximately $14,159,797.50. The trade was a 4.34% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
John C.M. Farquhar also recently made the following trade(s):
- On Monday, May 11th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $29.12, for a total transaction of $657,005.44.
- On Friday, April 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $26.72, for a total transaction of $602,856.64.
- On Wednesday, March 18th, John C.M. Farquhar sold 9,725 shares of Heartflow stock. The shares were sold at an average price of $25.00, for a total transaction of $243,125.00.
Heartflow Price Performance
Shares of HTFL stock opened at $33.24 on Friday. Heartflow, Inc. has a one year low of $20.13 and a one year high of $41.22. The firm has a 50-day moving average of $29.30 and a 200-day moving average of $28.34. The company has a market cap of $2.87 billion and a P/E ratio of -10.69.
Heartflow (NASDAQ:HTFL - Get Free Report) last released its quarterly earnings data on Thursday, May 14th. The company reported ($0.16) earnings per share for the quarter, beating analysts' consensus estimates of ($0.24) by $0.08. The business had revenue of $52.59 million during the quarter. The firm's revenue for the quarter was up 41.3% compared to the same quarter last year. As a group, research analysts expect that Heartflow, Inc. will post -0.82 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Heartflow
Hedge funds have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd bought a new stake in shares of Heartflow in the 4th quarter worth approximately $27,000. Russell Investments Group Ltd. bought a new stake in shares of Heartflow in the 4th quarter worth approximately $45,000. Essential Partners LLC bought a new stake in shares of Heartflow in the 1st quarter worth approximately $57,000. Legal & General Group Plc bought a new stake in shares of Heartflow in the 3rd quarter worth approximately $59,000. Finally, Strs Ohio bought a new stake in Heartflow during the 4th quarter valued at $99,000.
Wall Street Analyst Weigh In
Several brokerages recently commented on HTFL. Piper Sandler reaffirmed an "overweight" rating on shares of Heartflow in a research note on Thursday. Canaccord Genuity Group reduced their price objective on shares of Heartflow from $43.00 to $37.00 and set a "buy" rating for the company in a research note on Friday, May 15th. JPMorgan Chase & Co. reduced their price objective on shares of Heartflow from $40.00 to $35.00 and set an "overweight" rating for the company in a research note on Thursday, March 19th. William Blair started coverage on shares of Heartflow in a research report on Monday, May 4th. They set an "outperform" rating for the company. Finally, Wells Fargo & Company lifted their target price on shares of Heartflow from $35.00 to $37.00 and gave the company an "overweight" rating in a research report on Friday, May 15th. Six research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $37.00.
View Our Latest Stock Analysis on HTFL
Heartflow Company Profile
(
Get Free Report)
HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.
HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
